Xenetic Biosciences - Warrants (19/07/2024) ETF News

Healthcare > Biotechnology

Buy XBIOW

*Your capital is at risk

$17.54

+0 (+0%)

At Close: Oct 15, 2024

The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission

11:33am, Friday, 16'th Aug 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 15) Novocure Ltd (NASDAQ: NVCR ) Down In The Dumps (Bi

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by